Performance Characteristics of Six Intact Parathyroid Hormone Assays
- 1 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 134 (6), 930-938
- https://doi.org/10.1309/ajcplgczr7ipvha7
Abstract
The aim of this study was to evaluate the performance characteristics of 6 intact parathyroid hormone assays: Access 2 (Beckman Coulter, Fullerton, CA), ARCHITECT i2000SR (Abbott Diagnostics, Abbott Park, IL), ADVIA Centaur (Siemens Healthcare Diagnostics, Deerfield, IL), Modular E170 (Roche Diagnostics, Indianapolis, IN), IMMULITE 2000 (Siemens Healthcare Diagnostics), and LIAISON (DiaSorin, Stillwater, MN). Sample collection tubes and storage conditions were compared. Imprecision studies were performed using commercial quality control materials. Linearity was assessed using pools prepared from samples. For method comparison, serum and EDTA plasma samples were tested by all methods, and the ARCHITECT was used as the comparison method. Reference intervals were determined using various vitamin D cutoffs. The types of collection tubes and storage conditions are more important for some methods than others. Total coefficients of variation were 10.9% or less. The maximum deviation from the target recovery for linearity ranged from 5.0% to 82.2%. Bland-Altman plots demonstrated percentage biases ranging from −36.3% to 24.4%. The lower limit of the reference interval was not influenced by vitamin D status, whereas the upper reference limit was affected.Keywords
This publication has 19 references indexed in Scilit:
- Variation in Serum and Plasma PTH Levels in Second-Generation Assays in Hemodialysis Patients: A Cross-sectional StudyAmerican Journal of Kidney Diseases, 2008
- Stability of intact parathyroid hormone in samples from hemodialysis patientsKidney International, 2007
- Update on parathyroid hormone: New tests and new challenges for external quality assessmentClinical Biochemistry, 2007
- Lack of Comparability of Intact Parathyroid Hormone Measurements among Commercial Assays for End-Stage Renal Disease Patients: Implication for Treatment DecisionsClinical Chemistry, 2006
- Inter-method variability in PTH measurement: Implication for the care of CKD patientsKidney International, 2006
- Circulating PTH molecular forms: What we know and what we don'tKidney International, 2006
- The need for reliable serum parathyroid hormone measurementsKidney International, 2006
- Preanalytical Influences on DPC IMMULITE 2000 Intact PTH Assays of Plasma and Serum from Dialysis PatientsClinical Chemistry, 2005
- Hyperparathyroid and Hypoparathyroid DisordersThe New England Journal of Medicine, 2000
- The First International Reference Preparation of Human Parathyroid Hormone for Immunoassay: Characterization and Calibration by International Collaborative StudyJournal of Clinical Endocrinology & Metabolism, 1983